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Abstract
Background: Parasitic roundworms (nematodes) cause substantial morbidity and mortality in livestock animals
globally, and considerable productivity losses to farmers. The control of these nematodes has relied largely on
the use of a limited number of anthelmintics. However, resistance to many of these these anthelmintics is now
widespread, and, therefore, there is a need to find new drugs to ensure sustained and effective treatment and
control into the future.
Methods: Recently, we developed a screening assay to test natural, plant extracts with known inhibitory effects
against the free-living worm Caenorhabditis elegans. Using this assay, we assessed here the effects of the extracts on
motility and development of parasitic larval stages of Haemonchus contortus, one of the most important nematodes
of small ruminants worldwide.
Results: The study showed that two of five extracts from Picria fel-terrae Lour. have a significant inhibitory effect
(at concentrations of 3–5 mg/ml) on the motility and development of H. contortus larvae. Although the two
extracts originated from the same plant, they displayed different levels of inhibition on motility and development,
which might relate to the presence of various active constituents in these extracts, or the same constituents at
different concentrations in distinct parts of the plant.
Conclusions: These results suggest that extracts from P. fel-terrae Lour. have promising anthelmintic activity and
that more broadly, plant extracts are a potential rich source of anthelmintics to combat helminthic diseases.
Keywords: Medicinal plant extracts, Anthelmintic activity, Developmental assay, In vitro-assay
Background
Parasitic diseases cause major morbidity and mortality in
animals globally, and considerable losses to food produc-
tion. For instance, haemonchosis is one of the most signifi-
cant parasitic diseases of livestock worldwide, affecting
hundreds of millions of small ruminants (including sheep
and goats) and causing substantial losses to the livestock
industry estimated at tens of billions of dollars per annum
[1, 2]. The causative agent, Haemonchus contortus (barber’s
pole worm; Nematoda: Strongylida), feeds on blood in the
stomach (abomasum) and causes gastritis, anaemia and
associated complications, leading to production losses and
death in severely affected animals. This nematode is trans-
mitted orally from contaminated pasture to the host
through a complex life-cycle [3]: eggs are excreted in the
host faeces and hatch into first-stage larva (L1) usually
within 1 day and then develop through to the second (L2)
and third (L3) larval stages in about one week. Infective L3s
are then ingested by the host, exsheath (xL3) and, after a
histotrophic phase, develop through fourth-stage larvae
(L4) to dioecious adults (within 3 weeks) in the abomasum.
Although a vaccine (Barbervax®) was recently released
in Australia to support anthelmintic treatment programs
against haemonchosis, the control of H. contortus and
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related nematodes relies largely on the use of anthelmintic
drugs. The excessive use of such drugs has led to wide-
spread resistance in these nematodes to most classes of
anthelmintics [4–10], seriously compromising the control
of parasites in many countries. Although the development
of the compounds monepantel [11, 12] and derquantel
(2-deoxy-paraherquamide) [13] have provided fresh hope
for the development of new classes of nematocides,
success in discovering new drugs has been limited.
Natural compounds from plants provide a unique oppor-
tunity in the search for new, effective and safe anthelmintics
[14, 15]. In China, for example, plant-derived medicines
have been used (for centuries) to treat many disease condi-
tions in humans [16, 17] and other animals, including para-
sitic diseases [18–20]. It is likely that many of these natural
medicines may be acting on pathways in worms that differ
from targets of currently used anthelmintic drugs [21, 22]
and, therefore, might be able to kill nematodes that are
resistant to one or more anthelmintics. However, for
the vast majority of such natural compounds, there has
been limited systematic, scientific evaluation of efficacy,
mode of action and identity of their active compo-
nent(s) [23–25], and no plant-based anthelmintic is yet
commercially available.
Recently, we tested eight extracts (PE1 to PE8) from the
plants Picria fel-terrae Lour., Linariantha bicolor, Lansium
domesticum and Tetracera akara for nematocidal activity
against seven strains of the free-living nematode Caenor-
habditis elegans (one wild-type and six strains with GFP-
tagged stress response pathways), and characterised the
stress responses caused by these extracts [26]. These plants
are widely distributed throughout Asia and have been used
by indigenous Malaysian healers to treat worm infections
and gastrointestinal disorders in humans [26–28]. Five of
the eight plant extracts (designated PE1, PE2, PE4, PE5
and PE7; Table 1), had significant nematocidal activity
against both larval and adult stages of C. elegans [26]. The
most effective extracts were from P. fel-terrae [26], and
triggered stress response pathways that were distinct from
commercially available anthelmintics (doramectin and
levamisole). This study showed that using traditional
knowledge of plant medicinal properties, in combination
with a C. elegans in vitro-screen, provided a practical and
economical approach to search for nematocides. Despite
this progress, these plant extracts had not been tested on
any parasitic nematodes.
The recent development of a new and inexpensive
whole-organism assay for the rapid screening of chemical
compounds against parasitic stages of H. contortus [29, 30]
has provided a unique prospect to screen plant extracts for
activity against one of the most important parasitic nema-
todes of small ruminants, as a starting point for future as-
sessments on other nematodes. This screening assay,
which relies on video-capture to measure the inhibitory
properties of compounds on the motility of parasitic larval
stages of H. contortus and subsequent, morphological as-
sessment of larval development, was employed specifically
to screen extracts PE1, PE2, PE4, PE5 and PE7 against this
parasitic nematode.
Methods
Preparation of plant extracts for screening and assay
plate preparation
Plant extracts (Table 1) were prepared by the Sarawak
Biodiversity Centre (SBC), Kuching, Malaysia, as described
previously [26]. Briefly, whole plants, or parts thereof, were
dried, ground into a powder, extracted into 1:1 v/v dichlor-
omethane:methanol and then concentrated using a rotary
evaporator. Dried plant extracts were stored at SBC and
sent to Australia upon request. Before their use, the dried
plant extracts were dissolved in absolute ethanol (Merck,
Australia). Serial dilutions (1–5 mg/ml) of these extracts
(PE1, PE2, PE4, PE5 and PE7) were prepared in Luria
Bertani medium (LB) [10 g tryptone (cat no. LP0042; Oxoid
England), 5 g yeast extract (cat no. LP0042; Oxoid), 5 g
NaCl (cat no. K43208004210; Merck, Denmark) in 1 l of
sterile water]. LB was autoclaved and supplemented with
final concentrations of 2.5 μg/ml of amphotericin, 100 IU/
ml of penicillin and 100 μg/ml of streptomycin (Fungizone®,
antibiotic-antimycotic; cat no. 15240–062; Gibco); this
supplemented LB was designated LB*. Compounds were
then dispensed in 50 μl volumes in triplicate into the wells
of sterile 96-well, flat-bottom microplates (cat no. 3635;
Corning 3650, Life Sciences). The anthelmintic monepantel
(Zolvix®, Novartis Animal Health, Switzerland) was used at
20 μM as the positive-control compound, and LB* contain-
ing 1 % ethanol (Merck) was used as the negative-control.
Table 1 Sources of the plant extracts used in this study
Extract/origin SBC specimen reference number Plant species Plant family
PE1/whole plant A000423010301 Picria fel-terrae Lour. Scrophulariaceae
PE2/leaves A000423020301 Picria fel-terrae Lour. Scrophulariaceae
PE4/roots A001293020103 Linariantha bicolor Acanthaceae
PE5/leaves A001293030103 Linariantha bicolor Acanthaceae
PE7/whole plant A002698010103 Lansium domesticum Meliaceae
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Production of H. contortus and storage
Haemonchus contortus (Haecon-5 strain) was maintained
in experimental sheep as described previously [31], and in
accordance with the institutional animal ethics guidelines
(permit no. 1111938; The University of Melbourne). In
brief, helminth-free Merino sheep (eight weeks of age)
were inoculated intra-ruminally with 5,000 third-stage
larvae (L3s) of H. contortus. Four weeks after infection,
faecal samples were collected each day. L3s were produced
from eggs by incubating faeces at 27 °C for one week. Then,
L3s were sieved through two layers of nylon mesh (pore
size: 20 μM; Rowe Scientific, Australia) to remove debris or
dead larvae, and stored at 10 °C for up to three months.
Exsheathment of L3s
L3s were exsheathed and sterilised by incubation in
0.15 % v/v sodium hypochlorite (NaClO) at 37 °C for
20 min [32]. Following this incubation, exsheathed L3s
(xL3s) were washed five times in sterile physiological saline
by centrifugation at 600 x g (5 min) at room temperature
(22–24 °C). After the last wash, xL3s were suspended in
LB* at a density of 300 xL3 per 50 μl.
Screening xL3s for reduced motility upon exposure to
plant extracts
We assessed the effect of plant extracts on xL3 motility,
essentially as described recently [29, 30]. In brief, on 96-
well plates, test compounds (at concentrations ranging
from 1–5 mg/ml), the positive-control compound (mone-
pantel) and the ethanol-control in LB* were arrayed in
triplicate; six wells were used for the negative-control (LB*
+ 1 % ethanol). Then, 300 xL3s in 50 μl of LB* were trans-
ferred to each well of each plate (with the exception of
perimeter wells) using a multi-channel pipette. The final
concentration of the positive-control anthelmintic (mone-
pantel) was 20 μM, and plant extracts (Table 1) were indi-
vidually tested at 1, 2, 3, 4 and 5 mg/ml. Plates were
incubated at 38 °C and 10 % v/v CO2. After 48 and 72 h,
plates were agitated (126 rotations per min) using an
orbital shaker for 30 min at 38 °C. To capture the motility
of xL3s, a 10 s video recording of each well on each plate
was captured using an eyepiece camera (Dino-eye, ANMO
Electronic Corporation, Taiwan) attached to a stereo
dissecting microscope (Olympus, Japan). After 3 min of
imaging, plates were re-agitated for 5 min. The motility of
xL3s was recorded in each well on each plate. Each 10 s
video was processed using a custom macro in the program
Image J (1.47v, imagej.nih.gov/ij) to measure larval motil-
ity, represented by the motility index (= Mi), in each well
[30]. All extracts were tested individually in triplicate on
three different days. Differences in motility between
treated and untreated worms (negative-controls) were
assessed by statistical analysis using one-way ANOVA.
Evaluation of the effects of extracts on the development
of xL3 to L4
Following the measurement of larval motility, larvae in
5 mg/ml of plant extracts were re-incubated for four more
days at 38 °C and 10 % v/v CO2 in a humidified environ-
ment. Subsequently, worms were fixed through the addition
of 50 μl of 1 % iodine, and 30 worms from each well were
examined at 20x magnification to assess the development
of H. contortus L4s (based on the presence/absence of a
well-developed pharynx/mouth; cf. [29, 33]). The number
of L4s was expressed as a percentage of the total worm
number (n = 30). All compounds were tested in triplicate
on three different days. To establish whether the inhibitory
effect of individual plant extracts was reversible, a separate
(‘recovery’) assay was conducted: xL3s incubated at 5 mg/
ml plant extracts for 72 h (same conditions as above) were
washed four times with 200 μl LB* to remove extracts from
wells, fresh LB* (100 μl) added, and plates incubated for
four more days under the same conditions. Then, worms
were fixed in 1 % iodine and development to the L4 stage
assessed. Differences in development between treated and
untreated worms (negative-controls) were assessed by
statistical analysis using one-way ANOVA.
Results
To test the effects of the five plant extracts on the motil-
ity of xL3 stage of H. contortus, PE1, PE2, PE4, PE5 and
PE7 were each assessed at five concentrations (1, 2, 3, 4
and 5 mg/ml). Both PE1 and PE4 significantly reduced
xL3 motility in a dose-dependent manner with reference
to the negative-control. Although PE1 did not reduce
motility significantly at 1 and 2 mg/ml, it did at 3, 4 and
5 mg/ml (Fig. 1). PE4 significantly reduced xL3 motility
at 4 mg/ml and 5 mg/ml, but did not affect motility at
lower concentrations (Fig. 1). PE2 had a significant,
adverse effect on xL3 motility at all five concentrations
tested, but this effect was not dose dependent (Fig. 1).
Neither PE5 nor PE7 significantly reduced xL3 motility
with reference to negative-controls (Fig. 1). Although
PE1, PE2 and PE4 significantly inhibited xL3 motility
after 48 h (PE1: F(5, 48) = 28.77; PE2: F(5, 48) = 27.24; PE4:
F(5, 48) = 9.802; all P ≤ 0.001), these extracts did not
demonstrate statistically significant, time-dependent ef-
fects on these larvae, with no increased inhibition of
motility at 72 h (Fig. 2). Negative-controls showed a
constant motility index (Mi) throughout all experiments.
After seven days, the effects of individual extracts on L4
development were assessed (Fig. 3). After this time, 76.7 %
of untreated xL3s developed to L4s in negative-control
wells. By contrast, 17.3 % and 5.9 % of xL3s exposed to
5 mg/ml of PE1 and PE4, respectively, developed to L4s
after 7 days. Although PE2, PE5, PE7 and monepantel re-
duced the development of xL3 to L4, this reduction was
not significant (Fig. 3a). Approximately 80 % of untreated
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xL3s as well as xL3s exposed to extract PE2, PE4, PE5 or
PE7 (5 mg/ml each) or monepantel (20 μM) developed to
L4s following the addition of fresh LB*, after 72 h of incu-
bation. By contrast, only 41.8 % of xL3s exposed to extract
PE1 developed to L4s, even in the subsequent absence of
PE1, after incubation for 72 h (Fig. 3b).
Discussion
The present results show that extracts PE1 and PE2 from
P. fel-terrae Lour. have considerable activity against the
parasitic larval stages of H. contortus in vitro. Extract PE2
was the most effective inhibitor of xL3 motility at all con-
centrations tested, but with no observable dose-dependent
effect. This latter extract reduced worm motility, even at
the lowest concentration tested (1 mg/ml), which is consist-
ent with its effect on C. elegans [26]. Although PE1 and
PE2 originate from the same plant, they showed distinctive
inhibitory characteristics on both xL3 motility and L4
development of H. contortus, which might relate to the
presence of different active constituents in these extracts,
or the same constituents at different concentrations in
different parts of the plant. Interestingly, none of the plant
extracts showed significant, time-dependent effects on the
larvae at the time points tested. This finding may be due to:
(i) the active constituents in plant extracts having a max-
imum effect on H. contortus within 48 h; (ii) the degrad-
ation of active constituents in the extracts during testing in
the assay, such that they are no longer effective against
xL3s or L4s; (iii) xL3s may have rapidly developed an acute
“resistance” or used their defence mechanism to overcome
some of the effect(s) of the active constituent(s), for
instance, via a complex mechanism on the cuticle of the
worm [34–36].
In larval development and recovery assays, only PE1 had
an adverse impact on development from xL3 to L4. Even
though both PE1 and PE4 had a remarkable, adverse effect
on the development of xL3s to L4s, most PE4-treated
larvae recovered and developed to L4s after the removal of
the plant extract and replacement with LB*. This finding
suggests that the effect of extract PE4 is reversible, whereas
Fig. 1 The effects of plant extracts on exsheathed third-stage larvae (xL3) of Haemonchus contortus after 48 h. Results were calculated from three
biological and technical replicates (cf. Table 1) (300 worms per well per replicate). Error bar indicates the standard error of the mean (SEM).
Negative-control (NC) represents LB* containing 1 % ethanol. ***P ≤ 0.001
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PE1 appears to irreversibly inhibit xL3 motility and larval
development. Interestingly, a similar pattern to PE4 was
observed for monepantel at a dose of 20 μM. Given that
the nematodes can develop resistance rapidly (sometimes
after as few as three generations; [37]), a similar situation
might be the case for the active, natural compound PE4.
Fig. 2 The effects of plant extracts on exsheathed third-stage larvae (xL3) of Haemonchus contortus after 48 h and 72 h. Results were calculated from
three biological and technical replicates (cf. Table 1) (300 worms per replicate). Negative-control (NC) represents LB* containing 1 % ethanol. Error bar
indicates the standard error of the mean (SEM)
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Thus, resistance development in H. contortus should be
evaluated.
The finding that three of the same five plant extracts
shown previously to affect C. elegans [26] significantly re-
duced motility and development in xL3s of H. contortus in-
dicates variation between the free-living and parasitic
nematodes in targets and/or the pathways, which might
relate to genomic differences and evolutionary distance
between these worms [38–40]. However, it is also possible
that the absorption of constituents from the plant extracts
differs between the two worms [41], or that, from a
biological/evolutionary perspective, the parasitic nematode
(H. contortus) is perhaps more adapted to a plant extract-
rich environment in the abomasum of its ruminant host
compared with the soil nematode, C. elegans. These aspects
and differences in susceptibility or efficacy need to be taken
into consideration when the focus of screening is on
extracts or compounds expected to have an effect on a rela-
tively wide range of related nematodes
Conclusion
Significant activities previously identified for PE1 and PE2
in C. elegans in vitro [26] were also seen in H. contortus.
These findings suggest that extracts from P. fel-terrae
Lour. have promising anthelmintic effects. We propose
that future work should focus on attempting to fractionate
extract PE1, in order to identify and characterise the con-
stituent(s) that are active against H. contortus, and then to
explore which biological pathways are affected by these
components/fractions.
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